Kinfo
Harvard Bioscience Inc. logo

Harvard Bioscience Inc.

HBIONASDAQHealthcare·US · USD
$8.50
+0.16 (+1.92%)
Prices as of October 5, 2026 · market closed

Price

Key statistics

Valuation
Market cap37.97M USD
Enterprise value75.67M USD
Trailing P/E-0.65
Forward P/E12.93
PEG ratio-0.02
Price / sales0.43
Price / book5.12
Profitability
Gross margin55.57%
Operating margin-2.90%
Profit margin-11.86%
Return on assets1.57%
Return on equity-89.95%
Income (TTM)
Revenue87.81M USD
Gross profit51.07M USD
EBITDA2.52M USD
Net income-10.41M USD
Diluted EPS-$2.31
Rev. growth (YoY)11.10%
Balance sheet
Total cash6.50M USD
Total debt44.21M USD
Debt / equity595.93
Current ratio1.87
Book value / share$1.63
Cash flow (TTM)
Operating cash flow651.00K USD
Levered free cash flow5.30M USD
Shares & price
Shares outstanding4.55M
Float3.66M
Held by institutions42.01%
Beta1.53
50-day MA$7.34
200-day MA$6.28
52-week high$9.40
52-week low$3.80
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-11-0.21-0.14+33.33%2026-05-202.913.09+6.19%2026-05-080.110.13+18.18%2026-03-130.050.07+40.00%
About Harvard Bioscience Inc.

Harvard Bioscience Inc. is a life sciences tools and instruments company that develops, manufactures, and sells technologies, products, and services used in research, discovery, and preclinical testing. Harvard Bioscience’s offerings support a broad range of laboratory workflows, including cellular and molecular biology, electrophysiology, physiological measurement, data acquisition, and bioproduction. Its product portfolio serves academic institutions, pharmaceutical and biotechnology companies, contract research organizations, and government laboratories worldwide. The company’s current business is organized around specialized platforms for research instrumentation and preclinical systems, helping scientists generate and analyze data across drug discovery, therapy development, and laboratory experimentation. With operations and sales reach across major global markets, Harvard Bioscience holds a focused role in the life sciences tools sector as a supplier of precision instruments and related consumables for scientific and biomedical research.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. John Duke
Employees
316
Headquarters
Holliston, MA, United States

Frequently asked questions about Harvard Bioscience Inc.